Explore

Regeneron and Telix Partner in $4.3 Billion Radiopharmaceutical Collaboration

Regeneron and Telix Partner in $4.3 Billion Radiopharmaceutical Collaboration

Regeneron and Telix Partner in $4.3 Billion Radiopharmaceutical Collaboration

Telix Pharmaceuticals Gains FDA Acceptance for Brain Cancer Imaging Agent, Signaling New Revenue Stream

Telix Pharmaceuticals Gains FDA Acceptance for Brain Cancer Imaging Agent, Signaling New Revenue Stream

Telix Pharmaceuticals Gains FDA Acceptance for Brain Cancer Imaging Agent, Signaling New Revenue Stream

Telix Pharmaceuticals Advances in Radiopharmaceuticals with FDA Nod for Brain Cancer Imaging Agent

Telix Pharmaceuticals Advances in Radiopharmaceuticals with FDA Nod for Brain Cancer Imaging Agent

Telix Pharmaceuticals Advances in Radiopharmaceuticals with FDA Nod for Brain Cancer Imaging Agent

Regeneron Partners with Telix in $4.3 Billion Radiopharmaceutical Alliance

Regeneron Partners with Telix in $4.3 Billion Radiopharmaceutical Alliance

Regeneron Partners with Telix in $4.3 Billion Radiopharmaceutical Alliance

Kivu Bioscience to Present Preclinical Data on Next-Generation ADC Programs at AACR Annual Meeting

Kivu Bioscience to Present Preclinical Data on Next-Generation ADC Programs at AACR Annual Meeting

Kivu Bioscience to Present Preclinical Data on Next-Generation ADC Programs at AACR Annual Meeting

Hot dogs and steaks and bacon, oh my! Meat raffles keep a beloved Midwest tradition alive

Hot dogs and steaks and bacon, oh my! Meat raffles keep a beloved Midwest tradition alive

They're called meat raffles, and they're a tradition in a few pockets of the U.S. They're featured mainly at neighborhood bars or at American Legion or VFW posts in Minnesota, Wisconsin and New York state

Syracuse basketball: key offseason dates timeline & current roster tracker

Syracuse basketball: key offseason dates timeline & current roster tracker

Did you get enough Syracuse basketball news last week?

Telix Pharmaceuticals Launches $550 Million Convertible Bonds Offering

Telix Pharmaceuticals Launches $550 Million Convertible Bonds Offering

Telix Pharmaceuticals Launches $550 Million Convertible Bonds Offering

FDA Introduces New Safety Guidelines for Gene Editing Therapies to Accelerate Development

FDA Introduces New Safety Guidelines for Gene Editing Therapies to Accelerate Development

The FDA has released new draft safety guidelines aimed at standardizing the evaluation of genome editing therapies. These guidelines are designed to support the development of both ex vivo and in vivo gene editing products, with a focus on next-generation sequencing techniques to identify potential off-target effects. The initiative is part of the FDA's broader effort to expedite the development of personalized therapies, particularly for ultra-rare diseases. The guidelines provide a framework for nonclinical studies accompanying investigational new drug and biologics license applications, offering recommendations on sequencing strategies and sample analysis.

Regeneron Partners with Telix in $4.3 Billion Radiopharmaceuticals Deal Targeting Cancer

Regeneron Partners with Telix in $4.3 Billion Radiopharmaceuticals Deal Targeting Cancer

Regeneron Partners with Telix in $4.3 Billion Radiopharmaceuticals Deal Targeting Cancer

‘To us, they are heroes’: Celtics trio draws massive crowd in Boston

‘To us, they are heroes’: Celtics trio draws massive crowd in Boston

Celtics fans travelled from all over to attend a Jordan Walsh, Luka Garza, and Ron Harper Jr meet-and-greet in Boston, in celebration of a special Celtics season.

GSK Reports Positive Results for Ovarian Cancer Treatment, Boosting Future Sales Prospects

GSK Reports Positive Results for Ovarian Cancer Treatment, Boosting Future Sales Prospects

GSK Reports Positive Results for Ovarian Cancer Treatment, Boosting Future Sales Prospects